Amphotericin B versus Voriconazole in the treatment of fungal keratitis: a comparative study

被引:0
作者
Mervat, Mourad S. [1 ]
Ahmad, Ahmad H. [2 ]
机构
[1] Ain Shams Univ, Dept Ophthalmol, Cairo, Egypt
[2] Bristol Eye Hosp, Dept Ophthalmol, Bristol BS36 2XB, Avon, England
关键词
Amphotericin B; fungal keratitis; Voriconazole; DIAGNOSIS;
D O I
10.4103/ejos.ejos_4_22
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Evaluate the efficiency and safety of Voriconazole compared with Amphotericin B in the treatment of fungal keratitis. Background Fungal keratitis in Egypt is considered the second prevalent corneal infection after bacterial keratitis. It is one of the main causes of corneal blindness in Egypt. Many recalcitrant cases are frequently met with. Delay in the diagnosis and management usually leads to complications. Patients and methods During the period from July 2016 to October 2019, 106 patients who were clinically diagnosed in one eye as fungal keratitis, followed by culture and histopathological proof were recruited. They were divided into groups A and B. One hundred and six eyes of 106 patients whose age ranged from 10 to 74 years of both sexes were recruited, 53 eyes in each group. Group A received Amphotericin B while group B received Voriconazole. Adjuvant measures were used in deteriorating progressive cases in the form of cyanoacrylate glue with a high oxygen permeability contact lens in impending perforation, intrastromal Voriconazole injection, and lastly therapeutic penetrating keratoplasty. Follow-up was done on days 1, 3, 7, then weekly until cure. Size, depth, deep vascularization, presence of satellites, intraocular pressure monitoring, hypopyon, and any complication were recorded. Visual acuity and healing outcome and duration to achieve were also recorded. Results In all, 80 cases (39 of group A and 41 of group B) were healed, 21 cases (11 of group A and 10 of group B) progressed and needed adjuvant treatment to heal, five cases (three of group A and two of group B) needed urgent therapeutic penetrating keratoplasty. Voriconazole group showed a shorter time for healing and less complications. Discussion Voriconazole was slightly better than Amphotericin B as regards the duration for healing, progression of keratitis, extent of deep vascularization, density of the healed scar, and visual acuity. Conclusion Both Amphotericin B and Voriconazole were successful in treating fungal keratitis. Voriconazole showed statistically significant better results.
引用
收藏
页码:7 / 22
页数:16
相关论文
共 50 条
[31]   Clinically Significant Enhancement of Voriconazole Efficacy by Moxifloxacin and Gentamicin in Fungal Keratitis [J].
Matoba, Alice Y. ;
Divatia, Mukul K. ;
Arguello, Robert A. ;
Chevez-Barrios, Paty .
CORNEA, 2018, 37 (05) :651-654
[32]   Pharmacoeconomic Analysis of Liposomal Amphotericin B versus Voriconazole for Empirical Treatment of Febrile Neutropenia [J].
Curtis D. Collins ;
Emily R. Stuntebeck ;
Daryl D. DePestel ;
James G. Stevenson .
Clinical Drug Investigation, 2007, 27 :233-241
[33]   Voriconazole versus natamycin as primary treatment in fungal corneal ulcers [J].
Arora, Ritu ;
Gupta, Deepa ;
Goyal, Jawaharlal ;
Kaur, Ravinder .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (05) :434-440
[34]   In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis [J].
Diaz-Tome, Victoria ;
Garcia-Otero, Xurxo ;
Varela-Fernandez, Ruben ;
Martin-Pastor, Manuel ;
Conde-Penedo, Andrea ;
Aguiar, Pablo ;
Gonzalez-Barcia, Miguel ;
Fernandez-Ferreiro, Anxo ;
Otero-Espinar, Francisco J. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 597
[35]   Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group [J].
Herbrecht, Raoul ;
Patterson, Thomas F. ;
Slavin, Monica A. ;
Marchetti, Oscar ;
Maertens, Johan ;
Johnson, Elizabeth M. ;
Schlamm, Haran T. ;
Donnelly, J. Peter ;
Pappas, Peter G. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (05) :713-720
[36]   Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems [J].
Kumar, Gourav ;
Kalita, Aians H. ;
Ahmed, Jabin ;
Saxena, Shubhi ;
Sharma, Subhi ;
Mehta, Astha ;
Sharma, Amit ;
Das Kurmi, Balak ;
Das Gupta, Ghanshyam ;
Thakur, Shubham .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
[37]   A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus [J].
Krishnan, S ;
Manavathu, EK ;
Chandrasekar, PH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :914-920
[38]   Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis [J].
Al-Badriyeh, Daoud ;
Neoh, Chin Fen ;
Stewart, Kay ;
Kong, David C. M. .
CLINICAL OPHTHALMOLOGY, 2010, 4 :391-405
[39]   Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis [J].
Niki, Masanori ;
Eguchi, Hiroshi ;
Hayashi, Yuki ;
Miyamoto, Tatsuro ;
Hotta, Fumika ;
Mitamura, Yoshinori .
CLINICAL OPHTHALMOLOGY, 2014, 8 :1075-1079
[40]   Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit [J].
Edwar, Lukman ;
Janna, Yulia M. ;
Rozaliyani, Anna ;
Louisa, Melva .
MYCOSES, 2020, 63 (10) :1128-1132